Immunology
-
mRNA-based vaccines against SARS-CoV-2 do not stimulate interferon stimulatory gene expression in individuals affected by Aicardi Goutières Syndrome
This article has 18 authors:Reviewed by ScreenIT
-
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
This article has 6 authors:Reviewed by ScreenIT
-
Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis
This article has 10 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
The ATLAS™ screening assay reveals distinct CD4 + and CD8 + SARS-CoV-2 antigen response profiles which have implications to Omicron cellular immunity
This article has 12 authors:Reviewed by ScreenIT
-
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression
This article has 9 authors:Reviewed by ScreenIT
-
Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation
This article has 12 authors:Reviewed by ScreenIT
-
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
This article has 35 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV
This article has 7 authors:This article has been curated by 1 group:Reviewed by eLife
-
Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors
This article has 10 authors:This article has been curated by 1 group:Reviewed by eLife
-
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
This article has 34 authors:Reviewed by ScreenIT